Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rohde

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 5, 2023
Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findingsPhilipp Mathé, Siri Göpel, Daniel Hornuss, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2020
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiologyKyriaki Xanthopoulou, Silke Peter, David Tobys, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2022
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018Anna M Rohde, Sarah Walker, Michael Behnke, et al.
Toxicologic Pathology|November 15, 2013
Mechanistic investigations of test article-induced pancreatic toxicity at the endocrine-exocrine interface in the ratKarrie A Brenneman, Shashi K Ramaiah, Cynthia M Rohde, et al.
Scientific Reports|October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assaysDaniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Nature Communications|January 10, 2023
Resolving colistin resistance and heteroresistance in Enterobacter speciesSwapnil Prakash Doijad, Nicolas Gisch, Renate Frantz, et al.
NPJ Vaccines|October 7, 2024
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccinesTeresa Hauguel, Amy Sharma, Emily Mastrocola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersDivya Mathur, Adam R Root, Bozena Bugaj-Gaweda, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 5, 2023
Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findingsPhilipp Mathé, Siri Göpel, Daniel Hornuss, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2020
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiologyKyriaki Xanthopoulou, Silke Peter, David Tobys, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2022
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018Anna M Rohde, Sarah Walker, Michael Behnke, et al.
Toxicologic Pathology|November 15, 2013
Mechanistic investigations of test article-induced pancreatic toxicity at the endocrine-exocrine interface in the ratKarrie A Brenneman, Shashi K Ramaiah, Cynthia M Rohde, et al.
Scientific Reports|October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assaysDaniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Nature Communications|January 10, 2023
Resolving colistin resistance and heteroresistance in Enterobacter speciesSwapnil Prakash Doijad, Nicolas Gisch, Renate Frantz, et al.
NPJ Vaccines|October 7, 2024
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccinesTeresa Hauguel, Amy Sharma, Emily Mastrocola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersDivya Mathur, Adam R Root, Bozena Bugaj-Gaweda, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 29